Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
THE SO WHAT
Hims & Hers locking in a GLP-1 supply deal with Lilly—while agreeing not to compound—shows how access and compliance can be turned into a consumer-health growth story. Digital health players need to secure upstream pharma relationships early if they want to ride the GLP-1 wave.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechTSMC is weighing a move into AI memory chips at Nvidia’s request
If TSMC moves into 3D DRAM at Nvidia’s request, the memory bottleneck in AI shifts from merchant DRAM to vertically coordinated supply between a dominant GPU buyer and the leading foundry. System builders should assume tighter coupling of logic and memory roadmaps—and less pricing slack—over the next node or two.
Deep & Emerging TechPS Logistics subsidiary acquires Tennessee-based trucking business
Regional trucking rollups like PS Logistics buying Roane Transportation are about density and network control in specific lanes. If you depend on fragmented carriers in the Southeast, expect pricing and service terms to consolidate as these networks thicken.
Deep & Emerging TechChip Stocks Roar Back as Strong Data Sink Bonds
Chip stocks ripping higher on macro data underscores how much the AI trade is riding narrative and rates, not just unit demand. If you’re planning multi-year hardware bets, separate market euphoria from actual order books and capacity signals.
Deep & Emerging TechNubank Halts Some Crypto Transactions, Citing Snag With Provider
Nubank freezing Brazilian crypto deposits and withdrawals after a provider issue—days after a $6.3 billion Binance hack—highlights how third-party infra risk can instantly become your customer problem. If you offer crypto rails, you need contingency plans and clear comms for upstream failures.